These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34480420)

  • 1. Advances in Encapsulation and Delivery Strategies for Islet Transplantation.
    Wu S; Wang L; Fang Y; Huang H; You X; Wu J
    Adv Healthc Mater; 2021 Oct; 10(20):e2100965. PubMed ID: 34480420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing longevity of immunoisolated pancreatic islet grafts by modifying both the intracapsular and extracapsular environment.
    Qin T; Smink AM; de Vos P
    Acta Biomater; 2023 Sep; 167():38-53. PubMed ID: 37392934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet Microencapsulation: Strategies and Clinical Status in Diabetes.
    Omami M; McGarrigle JJ; Reedy M; Isa D; Ghani S; Marchese E; Bochenek MA; Longi M; Xing Y; Joshi I; Wang Y; Oberholzer J
    Curr Diab Rep; 2017 Jul; 17(7):47. PubMed ID: 28523592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells.
    Jun Y; Kang AR; Lee JS; Park SJ; Lee DY; Moon SH; Lee SH
    Biomaterials; 2014 Jun; 35(17):4815-26. PubMed ID: 24636217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in islet encapsulation technologies.
    Desai T; Shea LD
    Nat Rev Drug Discov; 2017 May; 16(5):338-350. PubMed ID: 28008169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
    Dadheech N; James Shapiro AM
    Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet and stem cell encapsulation for clinical transplantation.
    Krishnan R; Alexander M; Robles L; Foster CE; Lakey JR
    Rev Diabet Stud; 2014; 11(1):84-101. PubMed ID: 25148368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durable Control of Autoimmune Diabetes in Mice Achieved by Intraperitoneal Transplantation of "Neo-Islets," Three-Dimensional Aggregates of Allogeneic Islet and "Mesenchymal Stem Cells".
    Westenfelder C; Gooch A; Hu Z; Ahlstrom J; Zhang P
    Stem Cells Transl Med; 2017 Jul; 6(7):1631-1643. PubMed ID: 28467694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering Strategies to Improve Islet Transplantation for Type 1 Diabetes Therapy.
    White AM; Shamul JG; Xu J; Stewart S; Bromberg JS; He X
    ACS Biomater Sci Eng; 2020 May; 6(5):2543-2562. PubMed ID: 33299929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygenation strategies for encapsulated islet and beta cell transplants.
    Papas KK; De Leon H; Suszynski TM; Johnson RC
    Adv Drug Deliv Rev; 2019 Jan; 139():139-156. PubMed ID: 31077781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoengineering Biomaterials in Cell-Based Therapy for Type 1 Diabetes.
    Derakhshankhah H; Sajadimajd S; Jahanshahi F; Samsonchi Z; Karimi H; Hajizadeh-Saffar E; Jafari S; Razmi M; Malvajerd SS; Bahrami G; Razavi M; Izadi Z
    Tissue Eng Part B Rev; 2022 Oct; 28(5):1053-1066. PubMed ID: 34696626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Current Status of Allogenic Islet Cell Transplantation.
    Czarnecka Z; Dadheech N; Razavy H; Pawlick R; Shapiro AMJ
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogel materials for the application of islet transplantation.
    Xu L; Guo Y; Huang Y; Xu Y; Lu Y; Wang Z
    J Biomater Appl; 2019 Apr; 33(9):1252-1264. PubMed ID: 30791850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the design of implantable insulin secreting heterocellular islet organoids.
    Akolpoglu MB; Inceoglu Y; Bozuyuk U; Sousa AR; Oliveira MB; Mano JF; Kizilel S
    Biomaterials; 2021 Feb; 269():120627. PubMed ID: 33401104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Bioluminescence for the Detection of the Fate of Pancreatic Islet Organoids Post-transplantation.
    Sun A; Kenyon E; Gudi M; Li W; Aguirre A; Wang P
    Methods Mol Biol; 2023; 2592():195-206. PubMed ID: 36507995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D Bioprinting for Artificial Pancreas Organ.
    Lee SJ; Lee JB; Park YW; Lee DY
    Adv Exp Med Biol; 2018; 1064():355-374. PubMed ID: 30471043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets.
    Shi Y; Zhao YZ; Jiang Z; Wang Z; Wang Q; Kou L; Yao Q
    Front Immunol; 2022; 13():923241. PubMed ID: 35903090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering β Cell Replacement Therapies for Type 1 Diabetes: Biomaterial Advances and Considerations for Macroscale Constructs.
    Quizon MJ; García AJ
    Annu Rev Pathol; 2022 Jan; 17():485-513. PubMed ID: 34813353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement.
    Wan XX; Zhang DY; Khan MA; Zheng SY; Hu XM; Zhang Q; Yang RH; Xiong K
    Front Endocrinol (Lausanne); 2022; 13():859638. PubMed ID: 35370989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current progress in stem cell therapy for type 1 diabetes mellitus.
    Chen S; Du K; Zou C
    Stem Cell Res Ther; 2020 Jul; 11(1):275. PubMed ID: 32641151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.